Clin2
NCT05067595Possibly a fitRecruiting

Fecal transplant and fiber for gut graft-versus-host disease

Intestinal Graft Versus Host Disease

Treatments studied

Part of Blood & lymphatic, Digestive system clinical trials.

This study tests whether a fecal microbiota transplant (a procedure that puts healthy donor bacteria into your gut) combined with a dietary fiber supplement can help treat gut graft-versus-host disease, a common complication after a stem cell transplant. It may help reduce diarrhea and other gut symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
72 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You had a stem cell transplant within the last year.
  • You have mild to severe gut graft-versus-host disease, confirmed by symptoms or biopsy.
  • You are able to take the fecal transplant by mouth or through a colonoscopy.
  • You are willing to collect stool samples and complete surveys.
  • You are not pregnant or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03148743Recruiting
Fecal transplant for gut graft-versus-host disease

This study tests whether a fecal transplant (FMT) can help treat gut graft-versus-host disease (gut GVHD), a condition where donated immune cells attack the intestines. If you have gut GVHD and meet age requirements, you may be eligible to receive this treatment in the trial.

Suzhou, Jiangsu
NCT03819803Recruiting· Phase 3
Fecal transplant for gut graft-versus-host disease

This study tests whether restoring healthy gut bacteria using a fecal microbiota transplant can improve steroid-refractory gut graft-versus-host disease (aGvHD) after stem cell transplant. If your gut symptoms are your first episode and your stool bacteria diversity is low, this trial may be an option worth screening for.

Graz, Styria
NCT07602751Not yet recruiting· Phase 1/Phase 2
Fecal transplant for steroid-resistant gut graft-versus-host disease

This trial tests whether giving a fecal transplant (a procedure that transfers healthy bacteria from a donor's stool into your gut) can help children whose gut graft-versus-host disease (a common complication after a stem cell transplant) is not improving with standard steroid treatment.

Bologna
NCT07364617Recruiting· Phase 2
Fecal transplant for steroid-resistant gut GVHD

This study tests if a fecal transplant (transferring healthy bacteria from a donor's stool into your gut) can help people with severe gut graft-versus-host disease that hasn't responded to steroids. It's for patients who have had a stem cell transplant and now have ongoing, severe gut symptoms.

Taoyuan
NCT05664113Recruiting· Phase 1
Fecal transplant for gut problems after stem cell transplant

This study tests whether transplanting healthy donor stool into the gut can help children and young adults with ongoing digestive issues after a stem cell transplant. It may improve symptoms like diarrhea or the need for feeding tubes.

Memphis, Tennessee
NCT04935684Recruiting· Phase 2
Fecal transplant after bone marrow transplant to improve gut health

This Phase 2 study tests whether a fecal microbiota transplant (a processed transplant of gut bacteria) after an allogeneic bone marrow transplant is safe and helpful. Participants may benefit by improving recovery in the gut microbiome during the post-transplant period.

Amiens

Hear when a new Intestinal Graft Versus Host Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.